Literature DB >> 29135426

Integrated Supported Employment for People With Schizophrenia in Mainland China: A Randomized Controlled Trial.

Guo Fu Zhang1, Chi Man Tsui2, Aisia Jiang Bo Lu3, Li Bo Yu4, Hector Wing Hong Tsang5, Da Li6.   

Abstract

OBJECTIVE: In this randomized controlled trial, we investigated the effectiveness of integrated supported employment (ISE) compared with individual placement and support (IPS) and traditional vocational rehabilitation (TVR) for people with schizophrenia in mainland China.
METHOD: One hundred and sixty-two participants with schizophrenia were randomly assigned to ISE (n = 54), IPS (n = 54), or TVR (n = 54). Blinded assessments of employment status, job tenure, and psychological outcomes were conducted at admission; completion of the 3-mo program; and follow-up at 7, 11, and 15 mo.
RESULTS: Significantly higher employment rate and longer job tenure were found in the ISE group (63.0%, 29.56 wk) compared with the IPS group (50.0%, 25.47 wk) and TVR group (33.3%, 9.91 wk). The ISE group also attained the most positive psychological outcomes.
CONCLUSION: Work-related social skills training embedded in ISE with generalization strategies can enhance vocational and nonvocational outcomes for people with schizophrenia in mainland China.
Copyright © 2017 by the American Occupational Therapy Association, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 29135426     DOI: 10.5014/ajot.2017.024802

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  9 in total

1.  Community-based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence.

Authors:  Helen Killaspy; Carol Harvey; Catherine Brasier; Lisa Brophy; Priscilla Ennals; Justine Fletcher; Bridget Hamilton
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

2.  Who benefits from individual placement and support? A meta-analysis.

Authors:  Lars de Winter; Chrisje Couwenbergh; Jaap van Weeghel; Sarita Sanches; Harry Michon; Gary R Bond
Journal:  Epidemiol Psychiatr Sci       Date:  2022-07-11       Impact factor: 7.818

3.  Access to Services from Persons with Disabilities in Afghanistan: Is Community Based Rehabilitation Making a Difference?

Authors:  Jean-Francois Trani; Kyle A Pitzer; Juanita Vasquez Escallon; Parul Bakhshi
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

4.  Supported employment: Meta-analysis and review of randomized controlled trials of individual placement and support.

Authors:  Donald E Frederick; Tyler J VanderWeele
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

5.  Employability of Persons With Mental Disability: Understanding Lived Experiences in Kenya.

Authors:  Ikenna D Ebuenyi; Mònica Guxens; Elizabeth Ombati; Joske F G Bunders-Aelen; Barbara J Regeer
Journal:  Front Psychiatry       Date:  2019-07-30       Impact factor: 4.157

6.  Perspectives of mental healthcare providers on pathways to improved employment for persons with mental disorders in two lower middle-income countries.

Authors:  Ikenna D Ebuenyi; Barbara J Regeer; Chinyere Aguocha; Joske F G Bunders-Aelen; Mònica Guxens
Journal:  Int J Ment Health Syst       Date:  2020-03-30

7.  Coping with personal care and stigma: experiences of persons living with schizophrenia.

Authors:  Isaac Tetteh Commey; Jerry Paul K Ninnoni; Evelyn Asamoah Ampofo
Journal:  BMC Nurs       Date:  2022-05-06

Review 8.  Economic analyses of supported employment programmes for people with mental health conditions: A systematic review.

Authors:  A-La Park; Miles Rinaldi; Beate Brinchmann; Eoin Killackey; Nils Abel P Aars; Arnstein Mykletun; David McDaid
Journal:  Eur Psychiatry       Date:  2022-08-19       Impact factor: 7.156

Review 9.  Barriers to and facilitators of employment for people with psychiatric disabilities in Africa: a scoping review.

Authors:  I D Ebuenyi; E V Syurina; J F G Bunders; B J Regeer
Journal:  Glob Health Action       Date:  2018       Impact factor: 2.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.